Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Leukotriene B5 (LTB5) is a leukotriene with diverse biological activities.1,2,3,4,5 It is a metabolite of eicosapentaenoic acid (EPA; Item Nos. 90110 | 90110.1 | 21908) formed through the 5-lipoxygenase (5-LO) pathway.6 LTB5 increases contraction of bullfrog lung strips ex vivo in a concentration-dependent manner.1 In vivo, LTB5 (100 nM) reduces tumor volume in mice injected with Tm1 murine melanoma cells.2 LTB5 also elicits chemokinesis and lysosomal enzyme release from polymorphonuclear leukocytes (PMNLs) 20- to 30-fold less, and induces platelet aggregation 8-fold less, potently than LTB4 (Item No. 20110).3,4,5
WARNING This product is not for human or veterinary use.
1. Leukotriene B4 and leukotriene B5 have binding sites on lung membranes and cause contraction of bullfrog lung. J. Pharmacol. Exp. Ther. 263(3), 1111-1117 (1992).
2. Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol. Cancer Res. 7(9), 1417-1424 (2009).
3. Characterization and biologic properties of 5,12-
4. Immunologically induced generation of tetraene and pentaene leukotrienes in the peritoneal cavities of Menhaden-
5. Biosynthesis and biological activity of leukotriene B5. Prostaglandins 27(2), 217-232 (1984).
6. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286(5770), 264-265 (1980).
Human and mouse eosinophils differ in their ability to biosynthesize eicosanoids, docosanoids, the endocannabinoid 2-
Quantitative profiling of inflammatory and pro-
Lipid storm within the lungs of severe COVID-